已收录 268921 条政策
 政策提纲
  • 暂无提纲
Imaging Risk in Multisystem Inflammatory Diseases
[摘要] Rheumatic diseases are immune-mediated inflammatory multisystem diseases with frequent cardiovascular manifestations including perimyocarditis, valvular disease, coronary artery disease, heart failure with or without preserved ejection fraction, pulmonary hypertension, aneurysms, and thrombosis. Echocardiography, carotid ultrasonography, cardiac computed tomography, cardiac magnetic resonance imaging, and positron emission tomography are valid diagnostic tools for the detection of the cardiovascular complications of the multisystem diseases that frequently determine prognosis. Furthermore, the findings of these methods may offer additive risk stratification in asymptomatic patients over the conventional risk scores used to assess cardiovascular risk in the primary prevention setting. Finally, the imaging methods offer a unique opportunity to monitor the effects of treatment on atherosclerotic lesions, coronary microcirculatory dysfunction, myocardial inflammation and fibrosis. However, studies are needed to investigate whether improvement of imaging markers by treatment or selection of treatment according to its effects on surrogate imaging markers is linked to improved prognosis. (C) 2019 by the American College of Cardiology Foundation.
[发布日期] 2019-12-01 [发布机构] 
[效力级别]  [学科分类] 
[关键词] cardiac imaging;cardiovascular risk;echocardiography;inflammatory diseases;rheumatoid arthritis;systemic lupus erythematosus;systemic sclerosis;vasculitis [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文